Status:
COMPLETED
Autologous Platelet Enriched Gel Versus Metalloproteinase Inhibitor in the Healing of Chronic Lower Leg Ulcers
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
Medtronic
Johnson & Johnson
Conditions:
Chronic Lower Leg Ulcer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Compare Autologous Platelet Enriched Gel versus Metalloproteinase Inhibitor in the healing of chronic lower leg ulcers.
Eligibility Criteria
Inclusion
- 18 year or older
- A non-healing chronic lower leg ulcer
- Platelet ranges of 150000 per ml circulating blood
Exclusion
- Presence of a tumor or metastatic disease
- Hypersensitive to collagen regenerated cellulose
- Hemodynamic unstable patient
- Hypercoagulability
- Heart decompensation or angina pectoris
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2010
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00658983
Start Date
April 1 2008
End Date
August 20 2010
Last Update
January 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000